(563147, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0005435', 'hemoperitoneum', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563148, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0006114', 'cardiac murmur', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563149, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563150, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0004010', 'increased diastolic filling velocity', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563151, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563152, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563153, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0005532', 'abnormal vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563154, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0003233', 'prolonged QT interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563155, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0020097', 'low mean heart rate adaptation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563156, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0010515', 'abnormal Q wave', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563157, 'HP:0031673', 'Orthodromic atrioventricular reentrant tachycardia', 'MP:0031170', 'abnormal vasculature physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(563158, 'HP:0033505', 'Livedo reticularis', 'MP:0002060', 'abnormal skin morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(563159, 'HP:0033505', 'Livedo reticularis', 'MP:0009931', 'abnormal skin appearance', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(563160, 'HP:0033505', 'Livedo reticularis', 'MP:0001191', 'abnormal skin condition', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(563161, 'HP:0033505', 'Livedo reticularis', 'MP:0003941', 'abnormal skin development', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(563162, 'HP:0033505', 'Livedo reticularis', 'MP:0009563', 'dyskeratosis', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(563163, 'HP:0033505', 'Livedo reticularis', 'MP:0011239', 'abnormal skin coloration', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(563164, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0010031', 'abnormal cranium size', 0.4067796610169492, 7.821422361825214, 1.7837027602752782, 'UPHENO:0087814', 'abnormal cranium morphology'),
(563165, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0000439', 'enlarged cranium', 0.4262295081967213, 7.821422361825214, 1.8258480239821713, 'UPHENO:0087814', 'abnormal cranium morphology'),
(563166, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0030282', 'broad supraoccipital bone', 0.453125, 9.252530554317739, 2.0475724425341406, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(563167, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0004421', 'enlarged parietal bone', 0.421875, 8.373527591151573, 1.8795164145378114, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(563168, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0030288', 'broad occipital bone', 0.453125, 9.252530554317739, 2.0475724425341406, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(563169, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0030278', 'thick neurocranium', 0.40298507462686567, 8.373527591151573, 1.8369558081811155, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(563170, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0004379', 'wide frontal bone', 0.42028985507246375, 9.252530554317739, 1.9719900419950769, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(563171, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0030316', 'enlarged neurocranium', 0.45, 8.373527591151573, 1.9411562059809118, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(563172, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0004375', 'enlarged frontal bone', 0.40298507462686567, 8.373527591151573, 1.8369558081811155, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(563173, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0000441', 'increased cranium width', 0.4444444444444444, 9.252530554317739, 2.027864838178076, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(563174, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0030315', 'small neurocranium', 0.4032258064516129, 8.373527591151573, 1.8375043988483195, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(563175, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0004386', 'enlarged interparietal bone', 0.42857142857142855, 8.373527591151573, 1.8943744830212697, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(563176, 'HP:0002280', 'Enlarged cisterna magna', 'MP:0030287', 'enlarged occipital bone', 0.43548387096774194, 8.373527591151573, 1.9095905867619578, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(563177, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0005141', 'liver hyperplasia', 0.4461538461538462, 14.022184767190119, 2.501210040232876, 'UPHENO:0001177', 'increased size of the liver'),
(563178, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0000599', 'enlarged liver', 0.46774193548387094, 14.022184767190119, 2.561008364437328, 'UPHENO:0001177', 'increased size of the liver'),
(563179, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0004847', 'abnormal liver weight', 0.4406779661016949, 13.062826751687464, 2.399270706792471, 'UPHENO:0075202', 'abnormal size of liver'),
(563180, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0003333', 'liver fibrosis', 0.41379310344827586, 10.450642782231284, 2.0795201152883345, 'UPHENO:0019492', 'abnormal liver morphology'),
(563181, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0000601', 'small liver', 0.43333333333333335, 13.062826751687464, 2.379192774674757, 'UPHENO:0075202', 'abnormal size of liver'),
(563182, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0002981', 'increased liver weight', 0.4264705882352941, 14.022184767190119, 2.445413949826808, 'UPHENO:0001177', 'increased size of the liver'),
(563183, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0004848', 'abnormal liver size', 0.4642857142857143, 13.062826751687464, 2.4626984892588357, 'UPHENO:0075202', 'abnormal size of liver'),
(563184, 'HP:0006564', 'Fluctuating hepatomegaly', 'MP:0003103', 'liver degeneration', 0.4067796610169492, 10.450642782231284, 2.0618217499011084, 'UPHENO:0019492', 'abnormal liver morphology'),
(563185, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563186, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563187, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563188, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563189, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563190, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563191, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563192, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563193, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563194, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563195, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563196, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563197, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563198, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563199, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563200, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563201, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563202, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563203, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563204, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563205, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563206, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563207, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563208, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563209, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563210, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563211, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563212, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563213, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563214, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563215, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563216, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563217, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563218, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563219, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563220, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563221, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563222, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563223, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563224, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563225, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563226, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563227, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563228, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563229, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563230, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563231, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563232, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563233, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563234, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563235, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563236, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563237, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563238, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563239, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563240, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563241, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563242, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563243, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563244, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563245, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563246, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563247, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563248, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563249, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563250, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563251, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563252, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563253, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563254, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563255, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563256, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563257, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563258, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563259, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563260, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563261, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563262, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563263, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563264, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563265, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563266, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563267, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563268, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563269, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563270, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563271, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563272, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563273, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563274, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563275, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563276, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563277, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563278, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563279, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563280, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563281, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563282, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563283, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563284, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563285, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563286, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563287, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563288, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563289, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563290, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563291, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563292, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563293, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563294, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563295, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563296, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563297, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563298, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563299, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563300, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563301, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563302, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563303, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563304, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563305, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563306, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563307, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563308, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563309, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563310, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563311, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563312, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563313, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563314, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563315, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563316, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563317, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563318, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563319, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563320, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563321, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563322, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563323, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563324, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563325, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563326, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563327, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563328, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563329, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563330, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563331, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563332, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563333, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563334, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563335, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563336, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563337, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563338, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563339, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563340, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563341, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563342, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563343, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563344, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563345, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563346, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563347, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563348, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563349, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563350, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563351, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563352, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563353, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563354, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563355, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563356, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563357, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563358, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563359, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563360, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563361, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563362, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563363, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563364, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563365, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563366, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563367, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563368, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563369, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563370, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563371, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563372, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563373, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563374, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563375, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563376, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563377, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563378, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563379, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563380, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563381, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563382, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563383, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563384, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563385, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563386, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563387, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563388, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563389, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563390, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563391, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563392, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563393, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563394, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563395, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563396, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563397, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563398, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563399, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563400, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563401, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563402, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563403, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563404, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563405, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563406, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563407, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563408, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563409, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563410, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563411, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563412, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563413, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563414, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563415, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563416, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563417, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563418, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563419, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563420, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563421, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563422, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563423, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563424, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563425, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563426, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563427, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563428, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563429, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563430, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563431, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563432, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563433, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563434, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563435, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563436, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563437, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563438, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563439, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563440, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563441, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563442, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563443, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563444, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563445, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563446, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563447, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563448, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563449, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563450, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563451, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563452, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563453, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563454, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563455, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563456, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563457, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563458, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563459, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563460, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563461, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563462, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563463, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563464, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563465, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563466, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563467, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563468, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563469, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563470, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563471, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563472, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563473, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563474, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563475, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563476, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563477, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563478, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563479, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563480, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563481, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563482, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563483, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563484, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563485, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563486, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563487, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563488, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563489, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563490, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563491, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563492, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563493, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563494, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563495, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563496, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563497, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563498, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563499, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563500, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563501, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563502, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563503, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563504, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563505, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563506, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563507, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563508, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563509, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563510, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563511, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563512, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563513, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563514, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563515, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563516, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563517, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563518, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563519, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563520, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563521, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563522, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563523, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563524, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563525, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563526, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563527, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563528, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563529, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563530, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563531, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563532, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563533, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563534, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563535, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563536, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563537, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563538, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563539, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563540, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563541, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563542, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563543, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563544, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563545, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563546, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563547, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563548, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563549, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563550, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563551, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563552, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563553, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563554, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563555, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563556, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563557, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563558, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563559, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563560, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563561, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563562, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563563, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563564, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563565, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563566, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563567, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563568, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563569, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563570, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563571, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563572, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563573, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563574, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563575, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563576, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563577, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563578, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563579, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563580, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563581, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563582, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563583, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563584, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563585, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563586, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563587, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563588, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563589, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563590, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563591, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563592, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563593, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563594, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563595, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563596, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563597, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563598, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563599, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563600, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563601, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563602, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563603, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563604, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563605, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563606, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563607, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563608, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563609, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563610, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563611, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563612, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563613, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563614, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563615, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563616, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563617, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563618, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563619, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563620, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563621, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563622, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563623, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563624, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563625, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563626, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563627, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563628, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563629, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563630, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563631, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563632, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563633, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563634, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563635, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563636, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563637, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563638, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563639, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563640, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563641, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563642, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563643, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563644, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563645, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563646, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563647, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563648, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563649, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563650, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563651, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563652, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563653, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563654, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563655, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563656, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563657, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563658, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563659, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563660, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563661, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563662, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563663, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563664, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563665, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563666, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563667, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563668, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563669, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563670, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563671, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563672, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563673, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563674, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563675, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563676, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563677, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563678, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563679, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563680, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563681, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563682, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563683, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563684, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563685, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563686, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563687, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563688, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563689, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563690, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563691, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563692, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563693, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563694, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563695, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563696, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563697, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563698, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563699, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563700, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563701, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563702, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563703, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563704, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563705, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563706, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563707, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563708, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563709, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563710, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563711, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563712, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563713, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563714, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563715, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563716, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563717, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563718, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563719, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563720, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563721, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563722, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563723, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563724, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563725, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563726, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563727, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563728, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563729, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563730, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563731, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563732, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563733, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563734, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563735, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563736, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563737, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563738, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563739, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563740, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563741, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563742, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563743, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563744, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563745, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563746, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563747, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563748, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563749, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563750, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563751, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563752, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563753, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563754, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563755, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563756, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563757, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563758, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563759, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563760, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563761, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563762, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563763, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563764, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563765, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563766, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563767, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563768, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563769, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563770, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563771, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563772, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563773, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563774, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563775, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563776, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563777, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563778, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563779, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563780, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563781, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563782, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563783, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563784, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563785, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563786, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563787, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563788, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563789, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563790, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563791, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563792, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563793, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563794, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563795, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563796, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563797, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563798, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563799, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563800, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563801, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563802, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563803, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563804, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563805, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563806, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563807, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563808, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563809, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563810, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563811, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563812, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563813, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563814, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563815, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563816, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563817, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563818, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563819, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563820, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563821, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563822, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563823, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563824, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563825, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563826, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563827, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563828, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563829, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563830, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563831, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563832, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563833, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563834, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563835, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563836, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563837, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563838, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563839, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563840, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563841, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563842, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563843, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563844, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563845, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563846, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563847, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563848, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563849, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563850, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563851, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563852, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563853, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563854, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563855, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563856, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563857, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563858, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563859, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563860, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563861, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563862, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563863, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563864, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563865, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563866, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563867, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563868, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563869, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563870, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563871, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563872, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563873, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563874, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563875, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563876, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563877, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563878, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563879, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563880, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563881, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563882, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563883, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563884, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563885, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563886, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563887, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563888, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563889, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563890, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563891, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563892, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563893, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563894, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563895, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563896, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563897, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563898, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563899, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563900, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563901, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563902, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563903, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563904, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563905, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563906, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563907, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563908, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563909, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563910, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563911, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563912, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563913, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563914, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563915, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563916, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563917, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563918, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563919, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563920, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563921, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563922, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563923, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563924, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563925, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563926, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563927, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563928, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563929, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563930, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563931, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563932, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563933, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563934, 'HP:0034094', 'Anti-angiotensin receptor type-1 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(563935, 'HP:0008978', 'Necrotizing myopathy', 'MP:0010290', 'increased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563936, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563937, 'HP:0008978', 'Necrotizing myopathy', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563938, 'HP:0008978', 'Necrotizing myopathy', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563939, 'HP:0008978', 'Necrotizing myopathy', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563940, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563941, 'HP:0008978', 'Necrotizing myopathy', 'MP:0005508', 'abnormal skeleton morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563942, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003199', 'calcified muscle', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563943, 'HP:0008978', 'Necrotizing myopathy', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563944, 'HP:0008978', 'Necrotizing myopathy', 'MP:0012413', 'decreased muscle tumor incidence', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563945, 'HP:0008978', 'Necrotizing myopathy', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563946, 'HP:0008978', 'Necrotizing myopathy', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563947, 'HP:0008978', 'Necrotizing myopathy', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563948, 'HP:0008978', 'Necrotizing myopathy', 'MP:0004233', 'abnormal muscle weight', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563949, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563950, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563951, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000767', 'abnormal smooth muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563952, 'HP:0008978', 'Necrotizing myopathy', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563953, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003397', 'increased muscle weight', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563954, 'HP:0008978', 'Necrotizing myopathy', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563955, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563956, 'HP:0008978', 'Necrotizing myopathy', 'MP:0009407', 'increased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563957, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563958, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563959, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563960, 'HP:0008978', 'Necrotizing myopathy', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563961, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000749', 'muscle degeneration', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563962, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003939', 'abnormal myotome morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563963, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003632', 'abnormal nervous system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563964, 'HP:0008978', 'Necrotizing myopathy', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563965, 'HP:0008978', 'Necrotizing myopathy', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563966, 'HP:0008978', 'Necrotizing myopathy', 'MP:0004818', 'increased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563967, 'HP:0008978', 'Necrotizing myopathy', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563968, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563969, 'HP:0008978', 'Necrotizing myopathy', 'MP:0004819', 'decreased skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563970, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000731', 'increased collagen deposition in the muscles', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563971, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000752', 'dystrophic muscle', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563972, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563973, 'HP:0008978', 'Necrotizing myopathy', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563974, 'HP:0008978', 'Necrotizing myopathy', 'MP:0004817', 'abnormal skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563975, 'HP:0008978', 'Necrotizing myopathy', 'MP:0010630', 'abnormal cardiac muscle tissue morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563976, 'HP:0008978', 'Necrotizing myopathy', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563977, 'HP:0008978', 'Necrotizing myopathy', 'MP:0031112', 'rhabdomyolysis', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563978, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002108', 'abnormal muscle morphology', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563979, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563980, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000733', 'abnormal muscle development', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563981, 'HP:0008978', 'Necrotizing myopathy', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563982, 'HP:0008978', 'Necrotizing myopathy', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563983, 'HP:0008978', 'Necrotizing myopathy', 'MP:0005503', 'abnormal tendon morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563984, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563985, 'HP:0008978', 'Necrotizing myopathy', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563986, 'HP:0008978', 'Necrotizing myopathy', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563987, 'HP:0008978', 'Necrotizing myopathy', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563988, 'HP:0008978', 'Necrotizing myopathy', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563989, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563990, 'HP:0008978', 'Necrotizing myopathy', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563991, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563992, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563993, 'HP:0008978', 'Necrotizing myopathy', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563994, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563995, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000736', 'delayed muscle development', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(563996, 'HP:0008978', 'Necrotizing myopathy', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563997, 'HP:0008978', 'Necrotizing myopathy', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(563998, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(563999, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564000, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564001, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564002, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564003, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564004, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564005, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564006, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564007, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564008, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564009, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564010, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564011, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564012, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564013, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564014, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564015, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564016, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564017, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564018, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564019, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564020, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564021, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564022, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564023, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564024, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564025, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564026, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564027, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564028, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564029, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564030, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564031, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564032, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564033, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564034, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564035, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564036, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564037, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564038, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564039, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564040, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564041, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564042, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564043, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564044, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564045, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564046, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564047, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564048, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564049, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564050, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564051, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564052, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564053, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564054, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564055, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564056, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564057, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564058, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564059, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564060, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564061, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564062, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564063, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564064, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564065, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564066, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564067, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564068, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564069, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564070, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564071, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564072, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564073, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564074, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564075, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564076, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564077, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564078, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564079, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564080, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564081, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564082, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564083, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564084, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564085, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564086, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564087, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564088, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564089, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564090, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564091, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564092, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564093, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564094, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564095, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564096, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564097, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564098, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564099, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564100, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564101, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564102, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564103, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564104, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564105, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564106, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564107, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564108, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564109, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564110, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564111, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564112, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564113, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564114, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564115, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564116, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564117, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564118, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564119, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564120, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564121, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564122, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564123, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564124, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564125, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564126, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564127, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564128, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564129, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564130, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564131, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564132, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564133, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564134, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564135, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564136, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564137, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564138, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564139, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564140, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564141, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564142, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564143, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564144, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564145, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564146, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564147, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564148, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564149, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564150, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564151, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564152, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564153, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564154, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564155, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564156, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564157, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564158, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564159, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564160, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564161, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564162, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564163, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564164, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564165, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564166, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564167, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564168, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564169, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564170, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564171, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564172, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564173, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564174, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564175, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564176, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564177, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564178, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564179, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564180, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564181, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564182, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564183, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564184, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564185, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564186, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564187, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564188, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564189, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564190, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564191, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564192, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564193, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564194, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564195, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564196, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564197, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564198, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564199, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564200, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564201, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564202, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564203, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564204, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564205, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564206, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564207, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564208, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564209, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564210, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564211, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564212, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564213, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564214, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564215, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564216, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564217, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564218, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564219, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564220, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564221, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564222, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564223, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564224, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564225, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564226, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564227, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564228, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564229, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564230, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564231, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564232, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564233, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564234, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564235, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564236, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564237, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564238, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564239, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564240, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564241, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564242, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564243, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564244, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564245, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564246, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564247, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564248, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564249, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564250, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564251, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564252, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564253, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564254, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564255, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564256, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564257, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564258, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564259, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564260, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564261, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564262, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564263, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564264, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564265, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564266, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564267, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564268, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564269, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564270, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564271, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564272, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564273, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564274, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564275, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564276, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564277, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564278, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564279, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564280, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564281, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564282, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564283, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564284, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564285, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564286, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564287, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564288, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564289, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564290, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564291, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564292, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564293, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564294, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564295, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564296, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564297, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564298, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564299, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564300, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564301, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564302, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564303, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564304, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564305, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564306, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564307, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564308, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564309, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564310, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564311, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564312, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564313, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564314, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564315, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564316, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564317, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564318, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564319, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564320, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564321, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564322, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564323, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564324, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564325, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564326, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564327, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564328, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564329, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564330, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564331, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564332, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564333, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564334, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564335, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564336, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564337, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564338, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564339, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564340, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564341, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564342, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564343, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564344, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564345, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564346, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564347, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564348, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564349, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564350, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564351, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564352, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564353, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564354, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564355, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564356, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564357, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564358, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564359, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564360, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564361, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564362, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564363, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564364, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564365, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564366, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564367, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564368, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564369, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564370, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564371, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564372, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564373, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564374, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564375, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564376, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564377, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564378, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564379, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564380, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564381, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564382, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564383, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564384, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564385, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564386, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564387, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564388, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564389, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564390, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564391, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564392, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564393, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564394, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564395, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564396, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564397, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564398, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564399, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564400, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564401, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564402, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564403, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564404, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564405, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564406, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564407, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564408, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564409, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564410, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564411, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564412, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564413, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564414, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564415, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564416, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564417, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564418, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564419, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564420, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564421, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564422, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564423, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564424, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564425, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564426, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564427, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564428, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564429, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564430, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564431, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564432, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564433, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564434, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564435, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564436, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564437, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564438, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564439, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564440, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564441, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564442, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564443, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564444, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564445, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564446, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564447, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564448, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564449, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564450, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564451, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564452, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564453, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564454, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564455, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564456, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564457, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564458, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564459, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564460, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564461, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564462, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564463, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564464, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564465, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564466, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564467, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564468, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564469, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564470, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564471, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564472, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564473, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564474, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564475, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564476, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564477, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564478, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564479, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564480, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564481, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564482, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564483, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564484, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564485, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564486, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564487, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564488, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564489, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564490, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564491, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564492, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564493, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564494, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564495, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564496, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564497, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564498, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564499, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564500, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564501, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564502, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564503, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564504, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564505, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564506, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564507, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564508, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564509, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564510, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564511, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564512, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564513, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564514, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564515, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564516, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564517, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564518, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564519, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564520, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564521, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564522, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564523, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564524, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564525, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564526, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564527, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564528, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564529, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564530, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564531, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564532, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564533, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564534, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564535, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564536, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564537, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564538, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564539, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564540, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564541, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564542, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564543, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564544, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564545, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564546, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564547, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564548, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564549, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564550, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564551, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564552, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564553, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564554, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564555, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564556, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564557, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564558, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564559, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564560, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564561, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564562, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564563, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564564, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564565, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564566, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564567, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564568, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564569, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564570, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564571, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564572, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564573, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564574, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564575, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564576, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564577, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564578, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564579, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564580, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564581, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564582, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564583, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564584, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564585, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564586, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564587, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564588, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564589, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564590, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564591, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564592, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564593, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564594, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564595, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564596, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564597, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564598, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564599, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564600, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564601, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564602, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564603, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564604, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564605, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564606, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564607, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564608, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564609, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564610, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564611, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564612, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564613, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564614, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564615, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564616, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564617, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564618, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564619, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564620, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564621, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564622, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564623, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564624, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564625, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564626, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564627, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564628, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564629, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564630, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564631, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564632, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564633, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564634, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564635, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564636, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564637, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564638, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564639, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564640, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564641, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564642, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564643, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564644, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564645, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564646, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564647, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564648, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564649, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564650, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564651, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564652, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564653, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564654, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564655, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564656, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564657, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564658, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564659, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564660, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564661, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564662, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564663, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564664, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564665, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564666, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564667, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564668, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564669, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564670, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564671, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564672, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564673, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564674, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564675, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564676, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564677, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564678, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564679, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564680, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564681, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564682, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564683, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564684, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564685, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564686, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564687, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564688, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564689, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564690, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564691, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564692, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564693, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564694, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564695, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564696, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564697, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564698, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564699, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564700, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564701, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564702, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564703, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564704, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564705, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564706, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564707, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564708, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564709, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564710, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564711, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564712, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564713, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564714, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564715, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564716, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564717, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564718, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564719, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564720, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564721, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564722, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564723, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564724, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564725, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564726, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564727, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564728, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564729, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564730, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564731, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564732, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564733, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564734, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564735, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564736, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564737, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564738, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564739, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564740, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564741, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564742, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564743, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564744, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564745, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564746, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564747, 'HP:0034114', 'Anti-hexokinase-1 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(564748, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0003381', 'vitreal fibroplasia', 0.4230769230769231, 7.832360208310102, 1.820354596599785, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(564749, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0002700', 'increased opacity of vitreous body', 0.4074074074074074, 7.832360208310102, 1.786326276565555, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(564750, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0006209', 'calcified intraocular region', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(564751, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0001289', 'persistence of hyaloid vascular system', 0.41509433962264153, 7.832360208310102, 1.803099661237597, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(564752, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(564753, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0006225', 'ocular rupture', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(564754, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0002697', 'abnormal eye size', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(564755, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0006200', 'vitreous body deposition', 0.4230769230769231, 7.832360208310102, 1.820354596599785, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(564756, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.40816326530612246, 7.832360208310102, 1.7879825831583462, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(564757, 'HP:0031154', 'Beaded vitreous appearance', 'MP:0002699', 'abnormal vitreous body morphology', 0.43137254901960786, 7.832360208310102, 1.8381145742032718, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(564758, 'HP:0410327', 'Dairy allergy', 'MP:0000392', 'accelerated hair follicle regression', 0.42105263157894735, 8.297292005324488, 1.8691165383198654, 'UPHENO:0054970', 'increased biological_process'),
(564759, 'HP:0410327', 'Dairy allergy', 'MP:0002420', 'abnormal adaptive immunity', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564760, 'HP:0410327', 'Dairy allergy', 'MP:0001845', 'abnormal inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564761, 'HP:0410327', 'Dairy allergy', 'MP:0020000', 'abnormal response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564762, 'HP:0410327', 'Dairy allergy', 'MP:0001800', 'abnormal humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564763, 'HP:0410327', 'Dairy allergy', 'MP:0002419', 'abnormal innate immunity', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564764, 'HP:0410327', 'Dairy allergy', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564765, 'HP:0410327', 'Dairy allergy', 'MP:0001835', 'abnormal antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564766, 'HP:0410327', 'Dairy allergy', 'MP:0001790', 'abnormal immune system physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564767, 'HP:0410327', 'Dairy allergy', 'MP:0005000', 'abnormal immune tolerance', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564768, 'HP:0410327', 'Dairy allergy', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564769, 'HP:0410327', 'Dairy allergy', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564770, 'HP:0410327', 'Dairy allergy', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564771, 'HP:0410327', 'Dairy allergy', 'MP:0005671', 'abnormal response to transplant', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(564772, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564773, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564774, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564775, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564776, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564777, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564778, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4166666666666667, 5.816527256141925, 1.5567764847249168, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(564779, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564780, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564781, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564782, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.45454545454545453, 5.816527256141925, 1.6260000078471883, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(564783, 'HP:0030248', 'Mesenteric venous thrombosis', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564784, 'HP:0000455', 'Broad nasal tip', 'MP:0030069', 'broad face', 0.4528301886792453, 9.252530554317739, 2.046906240322742, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(564785, 'HP:0000455', 'Broad nasal tip', 'MP:0000449', 'broad nasal bridge', 0.4406779661016949, 9.78271883249473, 2.0763016731796284, 'UPHENO:0087950', 'abnormal nose morphology'),
(564786, 'HP:0000455', 'Broad nasal tip', 'MP:0030251', 'broad frontonasal prominence', 0.41509433962264153, 9.252530554317739, 1.959763521520603, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(564787, 'HP:0000455', 'Broad nasal tip', 'MP:0020302', 'large horns', 0.40816326530612246, 5.9605885577567275, 1.559773473578871, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(564788, 'HP:0000455', 'Broad nasal tip', 'MP:0030068', 'large face', 0.43137254901960786, 5.9605885577567275, 1.603506869276408, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(564789, 'HP:0000455', 'Broad nasal tip', 'MP:0030063', 'abnormal face size', 0.40816326530612246, 5.913369942082322, 1.5535830793759942, 'UPHENO:0087472', 'abnormal face morphology'),
(564790, 'HP:0000455', 'Broad nasal tip', 'MP:0030189', 'broad snout', 0.46153846153846156, 9.252530554317739, 2.0664943061565446, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(564791, 'HP:0000455', 'Broad nasal tip', 'MP:0000434', 'megacephaly', 0.40816326530612246, 5.9605885577567275, 1.559773473578871, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(564792, 'HP:0000455', 'Broad nasal tip', 'MP:0030042', 'large forehead', 0.41509433962264153, 5.9605885577567275, 1.5729610837984207, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(564793, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0003099', 'retina detachment', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564794, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0001329', 'retina hyperplasia', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564795, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0020038', 'retina macular degeneration', 0.4117647058823529, 12.083585311854263, 2.230603943316695, 'UPHENO:0076777', 'abnormal macula lutea morphology'),
(564796, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0006186', 'retina fibrosis', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564797, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0001326', 'retina degeneration', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564798, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0020442', 'serous retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564799, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0020441', 'rhegmatogenous retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564800, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0006188', 'calcified retina', 0.417910447761194, 9.356059413574362, 1.9773707236649367, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564801, 'HP:0031420', 'Small yellow foveal lesion with surrounding gray zone', 'MP:0020443', 'tractional retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564802, 'HP:0000618', 'Blindness', 'MP:0006147', 'monocular blindness', 0.4318181818181818, 15.022184767190119, 2.5469300173159106, 'UPHENO:0078456', 'absent visual perception'),
(564803, 'HP:0000618', 'Blindness', 'MP:0005551', 'abnormal eye electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564804, 'HP:0000618', 'Blindness', 'MP:0005253', 'abnormal eye physiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564805, 'HP:0000618', 'Blindness', 'MP:0008144', 'nyctalopia', 0.4318181818181818, 15.022184767190119, 2.5469300173159106, 'UPHENO:0078456', 'absent visual perception'),
(564806, 'HP:0000618', 'Blindness', 'MP:0003096', 'increased corneal light-scattering', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564807, 'HP:0000618', 'Blindness', 'MP:0006145', 'legal blindness', 0.4318181818181818, 15.022184767190119, 2.5469300173159106, 'UPHENO:0078456', 'absent visual perception'),
(564808, 'HP:0000618', 'Blindness', 'MP:0006190', 'retina ischemia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564809, 'HP:0000618', 'Blindness', 'MP:0003011', 'delayed dark adaptation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564810, 'HP:0000618', 'Blindness', 'MP:0006148', 'binocular blindness', 0.4318181818181818, 15.022184767190119, 2.5469300173159106, 'UPHENO:0078456', 'absent visual perception'),
(564811, 'HP:0000618', 'Blindness', 'MP:0014132', 'abnormal tear film physiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564812, 'HP:0000618', 'Blindness', 'MP:0002001', 'blindness', 0.4418604651162791, 15.022184767190119, 2.5763752731877605, 'UPHENO:0078456', 'absent visual perception'),
(564813, 'HP:0000618', 'Blindness', 'MP:0001337', 'dry eyes', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564814, 'HP:0000618', 'Blindness', 'MP:0020860', 'abnormal cornea physiology', 0.4186046511627907, 8.795504987450572, 1.9188119493770963, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564815, 'HP:0000618', 'Blindness', 'MP:0002090', 'abnormal vision', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564816, 'HP:0000618', 'Blindness', 'MP:0013145', 'eye discharge', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564817, 'HP:0000618', 'Blindness', 'MP:0020218', 'abnormal tear production', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564818, 'HP:0000618', 'Blindness', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(564819, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4166666666666667, 5.816527256141925, 1.5567764847249168, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(564820, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564821, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564822, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564823, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564824, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.45454545454545453, 5.816527256141925, 1.6260000078471883, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(564825, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564826, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564827, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564828, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564829, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564830, 'HP:0005523', 'Lymphoproliferative disorder', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(564831, 'HP:0025170', 'Neuronal/glioneuronal neoplasm of the central nervous system', 'MP:0000778', 'abnormal nervous system tract morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564832, 'HP:0025170', 'Neuronal/glioneuronal neoplasm of the central nervous system', 'MP:0000955', 'abnormal spinal cord morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564833, 'HP:0025170', 'Neuronal/glioneuronal neoplasm of the central nervous system', 'MP:0002152', 'abnormal brain morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564834, 'HP:0031385', 'Megakaryocyte nucleus hypolobulation', 'MP:0013660', 'abnormal bone marrow hematopoietic cell morphology', 0.4444444444444444, 12.607147267911277, 2.3671029896301774, 'UPHENO:0085144', 'abnormal bone marrow cell morphology'),
(564835, 'HP:0031385', 'Megakaryocyte nucleus hypolobulation', 'MP:0002417', 'abnormal megakaryocyte morphology', 0.43103448275862066, 14.104646927382092, 2.465682297628206, 'UPHENO:0088145', 'abnormal megakaryocyte morphology'),
(564836, 'HP:0031385', 'Megakaryocyte nucleus hypolobulation', 'MP:0011747', 'myelofibrosis', 0.40816326530612246, 12.285219173023913, 2.239280056773342, 'UPHENO:0087355', 'abnormal bone marrow morphology'),
(564837, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011635', 'abnormal mitochondrial crista morphology', 0.425, 12.906707549770184, 2.3420825580351194, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564838, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011629', 'decreased mitochondrial number', 0.5, 14.87018167374507, 2.726736297640924, 'UPHENO:0046181', 'abnormal number of mitochondrion'),
(564839, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011628', 'increased mitochondrial number', 0.5, 14.87018167374507, 2.726736297640924, 'UPHENO:0046181', 'abnormal number of mitochondrion'),
(564840, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0020378', 'abnormal cell cytoskeleton morphology', 0.4166666666666667, 9.356059413574362, 1.9744260150710429, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(564841, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011634', 'abnormal mitochondrial inner membrane morphology', 0.4473684210526316, 12.906707549770184, 2.402926003340254, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564842, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011633', 'abnormal mitochondrial shape', 0.4473684210526316, 12.906707549770184, 2.402926003340254, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564843, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011631', 'decreased mitochondrial size', 0.4146341463414634, 12.906707549770184, 2.3133442603680674, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564844, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0020851', 'abnormal vacuole morphology', 0.4166666666666667, 9.356059413574362, 1.9744260150710429, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(564845, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0014239', 'abnormal intracellular organelle morphology', 0.4411764705882353, 9.356059413574362, 2.031667608319474, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(564846, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0006035', 'abnormal mitochondrial morphology', 0.4857142857142857, 12.906707549770184, 2.5037915724875752, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564847, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0014010', 'abnormal peroxisome morphology', 0.4166666666666667, 9.356059413574362, 1.9744260150710429, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(564848, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0009378', 'abnormal endoplasmic reticulum morphology', 0.4166666666666667, 9.356059413574362, 1.9744260150710429, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(564849, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011743', 'abnormal Golgi apparatus morphology', 0.4166666666666667, 9.356059413574362, 1.9744260150710429, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(564850, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.41935483870967744, 7.297292005324488, 1.7493297893508444, 'UPHENO:0067691', 'abnormal morphology of cellular_component'),
(564851, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011632', 'dilated mitochondrion', 0.40476190476190477, 12.906707549770184, 2.28563853923796, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564852, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011636', 'disorganized mitochondrial cristae', 0.4146341463414634, 12.906707549770184, 2.3133442603680674, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564853, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011630', 'increased mitochondrial size', 0.4146341463414634, 12.906707549770184, 2.3133442603680674, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564854, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0011637', 'abnormal mitochondrial matrix morphology', 0.4594594594594595, 12.906707549770184, 2.4351814869160644, 'UPHENO:0067707', 'abnormal morphology of mitochondrion'),
(564855, 'HP:0012102', 'Abnormal mitochondrial number', 'MP:0014238', 'abnormal ribosome morphology', 0.4166666666666667, 9.356059413574362, 1.9744260150710429, 'UPHENO:0085968', 'abnormal morphology of intracellular organelle'),
(564856, 'HP:0012795', 'Abnormal optic disc morphology', 'MP:0003099', 'retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564857, 'HP:0012795', 'Abnormal optic disc morphology', 'MP:0006186', 'retina fibrosis', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564858, 'HP:0012795', 'Abnormal optic disc morphology', 'MP:0006188', 'calcified retina', 0.4117647058823529, 9.356059413574362, 1.9627773823458092, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564859, 'HP:0012795', 'Abnormal optic disc morphology', 'MP:0001326', 'retina degeneration', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(564860, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0002414', 'abnormal myeloblast morphology/development', 0.40476190476190477, 10.541058077453503, 2.065579518110097, 'UPHENO:0085195', 'abnormal bone marrow cell'),
(564861, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0002417', 'abnormal megakaryocyte morphology', 0.42857142857142855, 12.607147267911277, 2.3244489916578335, 'UPHENO:0085144', 'abnormal bone marrow cell morphology'),
(564862, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0013694', 'abnormal granulocyte monocyte progenitor cell morphology', 0.42105263157894735, 12.607147267911277, 2.303968865644104, 'UPHENO:0085144', 'abnormal bone marrow cell morphology'),
(564863, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0002398', 'abnormal bone marrow cell morphology/development', 0.425, 10.541058077453503, 2.116589162524872, 'UPHENO:0085195', 'abnormal bone marrow cell'),
(564864, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0013660', 'abnormal bone marrow hematopoietic cell morphology', 0.47058823529411764, 12.607147267911277, 2.435728881649069, 'UPHENO:0085144', 'abnormal bone marrow cell morphology'),
(564865, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0008249', 'abnormal common lymphocyte progenitor cell morphology', 0.40425531914893614, 10.541058077453503, 2.064286510460318, 'UPHENO:0085195', 'abnormal bone marrow cell'),
(564866, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0008246', 'abnormal leukocyte morphology', 0.40425531914893614, 7.6803571148650525, 1.7620514228159103, 'UPHENO:0087339', 'abnormal hematopoietic system morphology'),
(564867, 'HP:0005561', 'Abnormal bone marrow cell morphology', 'MP:0011747', 'myelofibrosis', 0.43478260869565216, 12.285219173023913, 2.3111468236451747, 'UPHENO:0087355', 'abnormal bone marrow morphology'),
(564868, 'HP:0025475', 'Erythematous macule', 'MP:0009604', 'increased keratohyalin granule number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564869, 'HP:0025475', 'Erythematous macule', 'MP:0003652', 'abnormal skin turgor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564870, 'HP:0025475', 'Erythematous macule', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564871, 'HP:0025475', 'Erythematous macule', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564872, 'HP:0025475', 'Erythematous macule', 'MP:0008856', 'fetal bleb', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564873, 'HP:0025475', 'Erythematous macule', 'MP:0001210', 'skin ridges', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564874, 'HP:0025475', 'Erythematous macule', 'MP:0003941', 'abnormal skin development', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564875, 'HP:0025475', 'Erythematous macule', 'MP:0010016', 'variable depigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564876, 'HP:0025475', 'Erythematous macule', 'MP:0001212', 'skin lesions', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564877, 'HP:0025475', 'Erythematous macule', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564878, 'HP:0025475', 'Erythematous macule', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564879, 'HP:0025475', 'Erythematous macule', 'MP:0001216', 'abnormal epidermal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564880, 'HP:0025475', 'Erythematous macule', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564881, 'HP:0025475', 'Erythematous macule', 'MP:0001211', 'wrinkled skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564882, 'HP:0025475', 'Erythematous macule', 'MP:0001196', 'shiny skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564883, 'HP:0025475', 'Erythematous macule', 'MP:0001209', 'spontaneous skin ulceration', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564884, 'HP:0025475', 'Erythematous macule', 'MP:0004241', 'acantholysis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564885, 'HP:0025475', 'Erythematous macule', 'MP:0011239', 'abnormal skin coloration', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564886, 'HP:0025475', 'Erythematous macule', 'MP:0031309', 'skin cyst', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564887, 'HP:0025475', 'Erythematous macule', 'MP:0002095', 'abnormal skin pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564888, 'HP:0025475', 'Erythematous macule', 'MP:0000367', 'abnormal coat/ hair morphology', 0.41379310344827586, 6.904974582545727, 1.6903345413683823, 'UPHENO:0003811', 'abnormal skin of body'),
(564889, 'HP:0025475', 'Erythematous macule', 'MP:0003940', 'abnormal dermatome morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564890, 'HP:0025475', 'Erythematous macule', 'MP:0009607', 'decreased keratohyalin granule size', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564891, 'HP:0025475', 'Erythematous macule', 'MP:0008816', 'petechiae', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564892, 'HP:0025475', 'Erythematous macule', 'MP:0008854', 'bleb', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564893, 'HP:0025475', 'Erythematous macule', 'MP:0002897', 'blotchy skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564894, 'HP:0025475', 'Erythematous macule', 'MP:0009385', 'abnormal dermal pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564895, 'HP:0025475', 'Erythematous macule', 'MP:0003653', 'decreased skin turgor', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564896, 'HP:0025475', 'Erythematous macule', 'MP:0001202', 'skin photosensitivity', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564897, 'HP:0025475', 'Erythematous macule', 'MP:0005421', 'loose skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564898, 'HP:0025475', 'Erythematous macule', 'MP:0001208', 'blistering', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564899, 'HP:0025475', 'Erythematous macule', 'MP:0003853', 'dry skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564900, 'HP:0025475', 'Erythematous macule', 'MP:0009932', 'skin fibrosis', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564901, 'HP:0025475', 'Erythematous macule', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564902, 'HP:0025475', 'Erythematous macule', 'MP:0009605', 'decreased keratohyalin granule number', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564903, 'HP:0025475', 'Erythematous macule', 'MP:0031103', 'skin rash', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564904, 'HP:0025475', 'Erythematous macule', 'MP:0009931', 'abnormal skin appearance', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564905, 'HP:0025475', 'Erythematous macule', 'MP:0001192', 'scaly skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564906, 'HP:0025475', 'Erythematous macule', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564907, 'HP:0025475', 'Erythematous macule', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564908, 'HP:0025475', 'Erythematous macule', 'MP:0001193', 'psoriasis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564909, 'HP:0025475', 'Erythematous macule', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564910, 'HP:0025475', 'Erythematous macule', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564911, 'HP:0025475', 'Erythematous macule', 'MP:0001243', 'abnormal dermal layer morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564912, 'HP:0025475', 'Erythematous macule', 'MP:0003196', 'calcified skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564913, 'HP:0025475', 'Erythematous macule', 'MP:0009379', 'abnormal foot pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564914, 'HP:0025475', 'Erythematous macule', 'MP:0009603', 'absent keratohyalin granules', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564915, 'HP:0025475', 'Erythematous macule', 'MP:0009606', 'increased keratohyalin granule size', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564916, 'HP:0025475', 'Erythematous macule', 'MP:0009827', 'skin detachment', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564917, 'HP:0025475', 'Erythematous macule', 'MP:0005174', 'abnormal tail pigmentation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564918, 'HP:0025475', 'Erythematous macule', 'MP:0002060', 'abnormal skin morphology', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564919, 'HP:0025475', 'Erythematous macule', 'MP:0010206', 'pigment incontinence', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564920, 'HP:0025475', 'Erythematous macule', 'MP:0009441', 'delayed skin barrier formation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564921, 'HP:0025475', 'Erythematous macule', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564922, 'HP:0025475', 'Erythematous macule', 'MP:0013406', 'abnormal epidermal immune compartment', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564923, 'HP:0025475', 'Erythematous macule', 'MP:0001213', 'abnormal skin cell number', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564924, 'HP:0025475', 'Erythematous macule', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564925, 'HP:0025475', 'Erythematous macule', 'MP:0011160', 'dermal-epidermal separation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564926, 'HP:0025475', 'Erythematous macule', 'MP:0003717', 'pallor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564927, 'HP:0025475', 'Erythematous macule', 'MP:0002015', 'epithelioid cyst', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564928, 'HP:0025475', 'Erythematous macule', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564929, 'HP:0025475', 'Erythematous macule', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564930, 'HP:0025475', 'Erythematous macule', 'MP:0011515', 'purpura', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564931, 'HP:0025475', 'Erythematous macule', 'MP:0012078', 'abnormal tail ring morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564932, 'HP:0025475', 'Erythematous macule', 'MP:0003705', 'abnormal hypodermis morphology', 0.4074074074074074, 6.509554027552121, 1.6285086827350528, 'UPHENO:0002635', 'abnormal integument'),
(564933, 'HP:0025475', 'Erythematous macule', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564934, 'HP:0025475', 'Erythematous macule', 'MP:0001195', 'flaky skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564935, 'HP:0025475', 'Erythematous macule', 'MP:0001230', 'epidermal desquamation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564936, 'HP:0025475', 'Erythematous macule', 'MP:0001191', 'abnormal skin condition', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564937, 'HP:0025475', 'Erythematous macule', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564938, 'HP:0025475', 'Erythematous macule', 'MP:0001201', 'translucent skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564939, 'HP:0025475', 'Erythematous macule', 'MP:0001198', 'tight skin', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564940, 'HP:0025475', 'Erythematous macule', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564941, 'HP:0025475', 'Erythematous macule', 'MP:0009563', 'dyskeratosis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564942, 'HP:0025475', 'Erythematous macule', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(564943, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0004996', 'abnormal CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564944, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0005623', 'abnormal meninges morphology', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564945, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564946, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564947, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564948, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0006108', 'abnormal hindbrain development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564949, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0004203', 'abnormal cranial flexure morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564950, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564951, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0005277', 'abnormal brainstem morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564952, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000954', 'decreased oligodendrocyte progenitor number', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564953, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564954, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009679', 'abnormal spinal cord ventral column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564955, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0008025', 'brain vacuoles', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564956, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014062', 'nervous system inclusion bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564957, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0001891', 'hydrocephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564958, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564959, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014067', 'Hirano bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564960, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0010744', 'abnormal cervical flexure morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564961, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009694', 'abnormal spinal cord commissure morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564962, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0002653', 'abnormal ependyma morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564963, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0004998', 'decreased CNS synapse formation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564964, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0004166', 'abnormal limbic system morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564965, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0012711', 'diplomyelia', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564966, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009686', 'abnormal spinal cord medial motor column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564967, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014063', 'Lafora bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564968, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0020370', 'abnormal glymphatic system morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564969, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009023', 'abnormal spinal cord meninges morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564970, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014061', 'ethmocephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564971, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0013934', 'supratentorial ventricles enlargement', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564972, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0008857', 'myelencephalic blebs', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564973, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009682', 'abnormal anterior corticospinal tract morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564974, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0004250', 'tau protein deposits', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564975, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0010892', 'increased oligodendrocyte progenitor number', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564976, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0002184', 'abnormal innervation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564977, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000841', 'abnormal hindbrain morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564978, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009804', 'abnormal interventricular foramen morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564979, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000955', 'abnormal spinal cord morphology', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564980, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0021002', 'brain lesion', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564981, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564982, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000787', 'abnormal telencephalon morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564983, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0004997', 'increased CNS synapse formation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564984, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0001890', 'anencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564985, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0003632', 'abnormal nervous system morphology', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564986, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0020452', 'abnormal axon radial sorting', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564987, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0005112', 'abnormal spinal cord ventral horn morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564988, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0002778', 'meroanencephaly', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564989, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0008493', 'alpha-synuclein inclusion body', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564990, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009678', 'abnormal spinal cord lateral column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564991, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0013564', 'abnormal sensory circumventricular organ morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564992, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564993, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000913', 'abnormal brain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564994, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0003861', 'abnormal nervous system development', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(564995, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0012545', 'syringomyelia', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564996, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000830', 'abnormal diencephalon morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564997, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000897', 'abnormal midbrain morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564998, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0003214', 'neurofibrillary tangles', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(564999, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565000, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0008026', 'abnormal brain white matter morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565001, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565002, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0013935', 'basal brain tissue herniation', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565003, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014064', 'argyrophilic inclusion bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(565004, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0003232', 'abnormal forebrain development', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565005, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009677', 'abnormal spinal cord dorsal column morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565006, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014278', 'semilobar holoprosencephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565007, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0001889', 'delayed brain development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565008, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014066', 'Rosenthal fibers', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(565009, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0005157', 'holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565010, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014065', 'Lewy bodies', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(565011, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000847', 'abnormal metencephalon morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565012, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(565013, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0002152', 'abnormal brain morphology', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565014, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014276', 'lobar holoprosencephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565015, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009022', 'abnormal brain meninges morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565016, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565017, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0006282', 'abnormal spinal cord dorsal horn morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565018, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009037', 'abnormal subarachnoid space development', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565019, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0012260', 'encephalomeningocele', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(565020, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000778', 'abnormal nervous system tract morphology', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565021, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0012132', 'abnormal midbrain-hindbrain boundary morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565022, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000822', 'abnormal brain ventricle morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565023, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000783', 'abnormal forebrain morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565024, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0009032', 'abnormal subarachnoid cistern morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565025, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0002924', 'delayed CNS synapse formation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(565026, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0006007', 'abnormal basal ganglion morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565027, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0003864', 'abnormal midbrain development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565028, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0014277', 'alobar holoprosencephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565029, 'HP:0007348', 'Hypoplasia of the pyramidal tract', 'MP:0000914', 'exencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(565030, 'HP:0040053', 'Long lower eyelashes', 'MP:0031288', 'long eyelid cilia', 0.47619047619047616, 15.192109768632433, 2.689672467989934, 'UPHENO:0072394', 'increased length of the eyelash'),
(565031, 'HP:0034588', 'Crypt hyperplasia', 'MP:0004002', 'abnormal jejunum morphology', 0.4444444444444444, 10.249595263293191, 2.134332605892238, 'UPHENO:0002808', 'abnormal small intestine'),
(565032, 'HP:0034588', 'Crypt hyperplasia', 'MP:0011974', 'intestinal stenosis', 0.42857142857142855, 8.68828403063668, 1.929650304807659, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565033, 'HP:0034588', 'Crypt hyperplasia', 'MP:0008012', 'duodenum polyps', 0.41025641025641024, 10.249595263293191, 2.0506004387251484, 'UPHENO:0002808', 'abnormal small intestine'),
(565034, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000500', 'small intestinal prolapse', 0.41025641025641024, 10.249595263293191, 2.0506004387251484, 'UPHENO:0002808', 'abnormal small intestine'),
(565035, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000512', 'intestinal ulcer', 0.4166666666666667, 8.68828403063668, 1.9026608594541006, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565036, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000495', 'abnormal colon morphology', 0.4166666666666667, 8.68828403063668, 1.9026608594541006, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565037, 'HP:0034588', 'Crypt hyperplasia', 'MP:0003294', 'intussusception', 0.45454545454545453, 8.68828403063668, 1.9872644549545397, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565038, 'HP:0034588', 'Crypt hyperplasia', 'MP:0020324', 'jejunum polyps', 0.41025641025641024, 10.249595263293191, 2.0506004387251484, 'UPHENO:0002808', 'abnormal small intestine'),
(565039, 'HP:0034588', 'Crypt hyperplasia', 'MP:0014231', 'intestinal mucus accumulation', 0.45454545454545453, 8.68828403063668, 1.9872644549545397, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565040, 'HP:0034588', 'Crypt hyperplasia', 'MP:0005155', 'herniated intestine', 0.40540540540540543, 8.68828403063668, 1.8767731108787693, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565041, 'HP:0034588', 'Crypt hyperplasia', 'MP:0002580', 'duodenal lesions', 0.43243243243243246, 10.249595263293191, 2.1052927138889292, 'UPHENO:0002808', 'abnormal small intestine'),
(565042, 'HP:0034588', 'Crypt hyperplasia', 'MP:0003274', 'intestinal microaneurysm', 0.40540540540540543, 8.68828403063668, 1.8767731108787693, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565043, 'HP:0034588', 'Crypt hyperplasia', 'MP:0009053', 'abnormal anal canal morphology', 0.4166666666666667, 8.68828403063668, 1.9026608594541006, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565044, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000492', 'abnormal rectum morphology', 0.40540540540540543, 8.68828403063668, 1.8767731108787693, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565045, 'HP:0034588', 'Crypt hyperplasia', 'MP:0003319', 'anal fistula', 0.40540540540540543, 8.68828403063668, 1.8767731108787693, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565046, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000477', 'abnormal intestine morphology', 0.46875, 8.68828403063668, 2.018076594027329, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565047, 'HP:0034588', 'Crypt hyperplasia', 'MP:0008011', 'intestine polyps', 0.4411764705882353, 8.68828403063668, 1.9578218724144487, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565048, 'HP:0034588', 'Crypt hyperplasia', 'MP:0009485', 'distended ileum', 0.43243243243243246, 10.249595263293191, 2.1052927138889292, 'UPHENO:0002808', 'abnormal small intestine'),
(565049, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000489', 'abnormal large intestine morphology', 0.4411764705882353, 8.68828403063668, 1.9578218724144487, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565050, 'HP:0034588', 'Crypt hyperplasia', 'MP:0003262', 'intestinal/bowel diverticulum', 0.45454545454545453, 8.68828403063668, 1.9872644549545397, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565051, 'HP:0034588', 'Crypt hyperplasia', 'MP:0003273', 'duodenal ulcer', 0.41025641025641024, 10.249595263293191, 2.0506004387251484, 'UPHENO:0002808', 'abnormal small intestine'),
(565052, 'HP:0034588', 'Crypt hyperplasia', 'MP:0013948', 'intraembryonal intestine elongation', 0.42857142857142855, 8.68828403063668, 1.929650304807659, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565053, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000478', 'delayed intestine development', 0.42857142857142855, 8.68828403063668, 1.929650304807659, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565054, 'HP:0034588', 'Crypt hyperplasia', 'MP:0002581', 'abnormal ileum morphology', 0.4444444444444444, 10.249595263293191, 2.134332605892238, 'UPHENO:0002808', 'abnormal small intestine'),
(565055, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000496', 'abnormal small intestine morphology', 0.47058823529411764, 10.249595263293191, 2.1962101328042563, 'UPHENO:0002808', 'abnormal small intestine'),
(565056, 'HP:0034588', 'Crypt hyperplasia', 'MP:0003271', 'abnormal duodenum morphology', 0.4444444444444444, 10.249595263293191, 2.134332605892238, 'UPHENO:0002808', 'abnormal small intestine'),
(565057, 'HP:0034588', 'Crypt hyperplasia', 'MP:0010158', 'abnormal intestine development', 0.4411764705882353, 8.68828403063668, 1.9578218724144487, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565058, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000488', 'abnormal intestinal epithelium morphology', 0.4166666666666667, 8.68828403063668, 1.9026608594541006, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565059, 'HP:0034588', 'Crypt hyperplasia', 'MP:0000511', 'abnormal intestinal mucosa morphology', 0.4411764705882353, 8.68828403063668, 1.9578218724144487, 'UPHENO:0076783', 'abnormal intestine morphology'),
(565060, 'HP:0005348', 'Inspiratory stridor', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565061, 'HP:0005348', 'Inspiratory stridor', 'MP:0003298', 'choking', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(565062, 'HP:0005348', 'Inspiratory stridor', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565063, 'HP:0005348', 'Inspiratory stridor', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565064, 'HP:0005348', 'Inspiratory stridor', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565065, 'HP:0005348', 'Inspiratory stridor', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565066, 'HP:0005348', 'Inspiratory stridor', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565067, 'HP:0005348', 'Inspiratory stridor', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565068, 'HP:0005348', 'Inspiratory stridor', 'MP:0001947', 'abnormal mucociliary clearance', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(565069, 'HP:0005348', 'Inspiratory stridor', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565070, 'HP:0005348', 'Inspiratory stridor', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565071, 'HP:0005348', 'Inspiratory stridor', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565072, 'HP:0005348', 'Inspiratory stridor', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565073, 'HP:0005348', 'Inspiratory stridor', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565074, 'HP:0005348', 'Inspiratory stridor', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565075, 'HP:0005348', 'Inspiratory stridor', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565076, 'HP:0005348', 'Inspiratory stridor', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565077, 'HP:0005348', 'Inspiratory stridor', 'MP:0013498', 'trachea inflammation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(565078, 'HP:0005348', 'Inspiratory stridor', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565079, 'HP:0005348', 'Inspiratory stridor', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565080, 'HP:0005348', 'Inspiratory stridor', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565081, 'HP:0005348', 'Inspiratory stridor', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(565082, 'HP:0005348', 'Inspiratory stridor', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565083, 'HP:0005348', 'Inspiratory stridor', 'MP:0031053', 'pleuritis', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(565084, 'HP:0005348', 'Inspiratory stridor', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(565085, 'HP:0005348', 'Inspiratory stridor', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
